A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release

被引:53
作者
Takenaga, M [1 ]
Yamaguchi, Y [1 ]
Kitagawa, A [1 ]
Ogawa, Y [1 ]
Mizushima, Y [1 ]
Igarashi, R [1 ]
机构
[1] St Marianna Univ, Sch Med, Inst Med Sci, Miyamae Ku, Kawasaki, Kanagawa 2168512, Japan
关键词
controlled release; diabetes mellitus (DM); insulin; co-poly(D; L-lactic/glycolic); acids; (PLGA); diabetic rat;
D O I
10.1016/S0168-3659(01)00518-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To ensure a strictly controlled release of insulin. a preparation method for insulin-loaded microcapsules was designed. Microcapsules were prepared with an injectable. biodegradable polymer composed of co-poly(D.L -lactic/glycolic) acids (PLGA) (mean molecular weight 6600. LA/GA ratio 50:50). Morphological examination using scanning electron microphotography demonstrated spherical particles with a main diameter of 15-30 mum, When 3% insulin-loaded PLGA microcapsules were administered subcutaneously as a single dose (250 U/kg) to streptozotocin-induced hyperglycemic rats. plasma insulin levels increased and were sustained at levels showing hypoglycemic effects. When glycerin, ethanol, or distilled water was used throughout the preparation procedure, the resultant micrucapsules dramatically reduced the initial burst. The formulation in which glycerin was added to an oil phase containing PLGA, insulin. and ZnO increased plasma insulin levels to 86.7, 108.4, and 84.9 muU/ml at 1, 2, and 6 h, respectively. The levels remained at 36.2-140.7 muU/ml from day 1 to day 9. The AUC(0-24) (h)/AUC(0-336) (h) ratio was calculated to be 9.7%. The formulation prepared without additives gave such a rapid insulin release that animals receiving it became transiently hypoglycemic. (C) 2002 Elsevier Svience B.V. All rights reserved.
引用
收藏
页码:81 / 91
页数:11
相关论文
共 27 条
[1]   Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) :471-476
[2]   Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (02) :189-198
[3]   ONE MONTH OF SUSTAINED-RELEASE OF INSULIN FROM A POLYMER IMPLANT [J].
CREQUE, HM ;
LANGER, R ;
FOLKMAN, J .
DIABETES, 1980, 29 (01) :37-40
[4]   CONTROL OF DIABETES WITH POLYACRYLAMIDE IMPLANTS CONTAINING INSULIN [J].
DAVIS, BK .
EXPERIENTIA, 1972, 28 (03) :348-&
[5]   New concept for long-acting insulin - Spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin [J].
Gershonov, E ;
Shechter, Y ;
Fridkin, M .
DIABETES, 1999, 48 (07) :1437-1442
[6]   LONG-ACTING INSULIN - SLOW RELEASE OF INSULIN FROM A BIODEGRADABLE MATRIX IMPLANTED IN DIABETIC RATS [J].
GOOSEN, MFA ;
LEUNG, YF ;
OSHEA, GM ;
CHOU, S ;
SUN, AM .
DIABETES, 1983, 32 (05) :478-481
[7]  
HAAK T, 1999, EXP CLIN ENDOCRINOL, pS108
[8]  
JHONSON OL, 1996, NAT MED, V2, P795
[9]   The stabilization and encapsulation of human growth hormone into biodegradable microspheres [J].
Johnson, OL ;
Jaworowicz, W ;
Cleland, JL ;
Bailey, L ;
Charnis, M ;
Duenas, E ;
Wu, CC ;
Shepard, D ;
Magil, S ;
Last, T ;
Jones, AJS ;
Putney, SD .
PHARMACEUTICAL RESEARCH, 1997, 14 (06) :730-735
[10]   In vitro release test system of (D,L-lactic-glycolic) acid copolymer microcapsules for sustained release of LHRH agonist (leuprorelin) [J].
Kamijo, A ;
Kamei, S ;
Saikawa, A ;
Igari, Y ;
Ogawa, Y .
JOURNAL OF CONTROLLED RELEASE, 1996, 40 (03) :269-276